<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="791">
  <stage>Registered</stage>
  <submitdate>25/09/2005</submitdate>
  <approvaldate>5/10/2005</approvaldate>
  <actrnumber>ACTRN12605000603617</actrnumber>
  <trial_identification>
    <studytitle>Use of a local anaesthetic wound infusion to reduce morphine requirements following major abdominal surgery</studytitle>
    <scientifictitle>Use of a local anaesthetic wound infusion to reduce morphine requirements following major abdominal surgery</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Pain</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Use of ropivacaine via Stryker(R) Pain Pump system for 48 hours post-op to decrease the amount of PCA morphine required following major abdominal surgery requiring midline laparotomy.</interventions>
    <comparator>Saline</comparator>
    <control>Placebo</control>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Morphine PCA use</outcome>
      <timepoint>Measured at 4, 24, 48, 72 hours post-op</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Pain Scores at rest</outcome>
      <timepoint>Measured at 4, 24, 48, 72 hours .</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Coughing and sitting up Anti-emetic use Sedation scores.</outcome>
      <timepoint>Measured at 4, 24, 48, 72 hours .</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>American Society of Anesthesiology (ASA) physical status 1, 2 or 3 patients undergoing elective major abdominal surgery via midline laparotomy at Geelong Hospital.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnant; weight &lt;50kg; allergy to morphine or amide local anaesthetics; ASA physical status 4; severe renal disease ( eGFR &lt; 40ml/min ); significant hepatic impairment; severe respiratory disease (FEV1 &lt; 1.0 l) cognitive impairment or a history of chronic opioid use. Furthermore, patients may be excluded from the trial immediately post-operatively if they meet any of the following criteria: patients who remain intubated post-operatively; post-operative renal or hepatic failure; morphine intolerance or major surgical complications requiring a return to theatre such as sepsis, bleeding or anastomotic breakdown.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Study numbers allocated on recruitment. Study medication allocated by pharmacy according to central randomisation schedule kept by them and contents blinded to patients and researchers.</concealment>
    <sequence>computer software generated ('minitab')</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/11/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Simon Tomlinson, Department of Anaestheisa, Geelong Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Department of Anaesthesia, Geelong Hospital</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Mark Shulman, Department of Anaestheisa, Geelong Hospital</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Simon Tomlinson</name>
      <address>Department of Anaesthesia
The Geelong Hospital
Ryrie St
Geelong VIC 3220</address>
      <phone>+61 3 52267333</phone>
      <fax />
      <email>simon@barwonhealth.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Simon Tomlinson</name>
      <address>Department of Anaesthesia
The Geelong Hospital
Ryrie St
Geelong VIC 3220</address>
      <phone>+61 3 52267333</phone>
      <fax />
      <email>simon@barwonhealth.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>